Issues related to reforming and increasing transparency within the 340B Drug Pricing Program. Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, H.R.2880 - Protecting Patients Against PBM Abuses Act. S.2764/H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act of 2023 S.1375/H.R.830 - HELP Copays Act. Access and reimbursement for Part B and Part D drugs. Advocating for access to biosimilars. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALANNA TEMME JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS
LD, Rep. Jon Porter